November 21, 2024

Kidney Cancer NCCN Guidelines Receive Major Updates, Prostate Cancer Adds Targeted Agents – OncLive

November 21, 2024

Active Surveillance, Watchful Waiting Increased for Intermediate-Risk Prostate Cancer – HealthDay

November 21, 2024

Scientists can predict how long prostate cancer patients will respond to olaparib – The Institute of Cancer Research

November 21, 2024

Trial Results Support SBRT as a Standard Option for Some Prostate Cancers – NCI Cancer Bulletin

November 20, 2024

Study Unveils Key Strategies Against Drug-Resistant Prostate Cancer – Weill Cornell Medicine Newsroom